Our findings in a large, population-based registry of over 20 000 patients with a recent hospitalization for documented HF suggest that prescription of a non-selective beta-blocker is associated with ...
A major international study suggests beta blockers may not benefit many patients recovering from uncomplicated heart attacks ...
A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for ...
What recommendations would you offer to clinicians regarding shared decision-making with patients regarding this issue? Dr Granger: Based on the REDUCE-AMI trial results, I would recommend that ...
Imagine someone you care about suddenly experiencing chest pain, turning pale, and breathing heavily. These are some of the symptoms of a heart attack. Cardiovascular diseases (CVDs) are the leading ...
Hosted on MSN
After a heart attack, beta-blockers are often a lifelong medicine. Maybe they shouldn’t be
For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help protect your heart. But doctors are taking a closer look at whether ...
Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Beta-blockers did not improve clinical outcomes after ...
A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide clear benefits for heart attack patients ...
Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no beta-blocker therapy in the subgroup of ...
Beta-blocker use is associated with a 34% reduction of onset in premanifest Huntington disease (preHD) and slower progression in early motor-manifest Huntington disease (mmHD), new research shows. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results